0001846600-21-000002.txt : 20210223 0001846600-21-000002.hdr.sgml : 20210223 20210223163357 ACCESSION NUMBER: 0001846600-21-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210223 DATE AS OF CHANGE: 20210223 EFFECTIVENESS DATE: 20210223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THEON Therapeutics, Inc. CENTRAL INDEX KEY: 0001846600 IRS NUMBER: 854033301 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-390235 FILM NUMBER: 21666083 BUSINESS ADDRESS: STREET 1: 1313 WASHINGTON STREET STREET 2: SUITE 202 CITY: BOSTON STATE: MA ZIP: 02139 BUSINESS PHONE: 6175465726 MAIL ADDRESS: STREET 1: 1313 WASHINGTON STREET STREET 2: SUITE 202 CITY: BOSTON STATE: MA ZIP: 02139 D 1 primary_doc.xml X0708 D LIVE 0001846600 THEON Therapeutics, Inc. 1313 WASHINGTON STREET SUITE 202 BOSTON MA MASSACHUSETTS 02139 6175465726 DELAWARE None None Corporation true 2020 Nicholas K. Davis c/o THEON Therapeutics, Inc. 1313 WASHINGTON STREET, SUITE 202 BOSTON MA MASSACHUSETTS 02139 Executive Officer Director Lee Cooper c/o THEON Therapeutics, Inc. 1313 WASHINGTON STREET, SUITE 202 BOSTON MA MASSACHUSETTS 02139 Director Donna See c/o THEON Therapeutics, Inc. 1313 WASHINGTON STREET, SUITE 202 BOSTON MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2021-02-10 true true false 0 9999999 2849999 7150000 false 4 0 0 0 false THEON Therapeutics, Inc. /s/ Nicholas K. Davis Nicholas K. Davis President and Chief Executive Officer 2021-02-23